Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Neuropharmacology of Paroxetine
1 x
$
30.00
View Cart
Checkout
Home
Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
“Neuropharmacology of Paroxetine” has been added to your cart.
View cart
Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
$
30.00
Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
acetylcholine
,
dopamine
,
elliott-richelson
,
histamine
,
norepinephrine
,
serotonin
Description
Description
Elliott Richelson, MD
GENERAL PSYCHOPHARMACOLOGY
The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
Elliott Richelson, MD
Related products
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Page load link
Go to Top